The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

PubChem24224     9-(oxolan-2-yl)purin-6-amine

Synonyms: CHEMBL64239, SureCN896095, S153_SIGMA, AG-K-90886, BSPBio_001142, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of AX 100

  • ATP-induced stimulation of alpha-MG uptake was blocked by pertussis toxin (PTX, a G(i) protein inhibitor), SQ-22536 (an adenylate cyclase inhibitor), and PKA inhibitor amide 14-22 (PKI) [1].

Psychiatry related information on AX 100

  • To test this hypothesis, four different doses (0.25, 0.50, 0.75, and 1.0 nmol) of a specific adenylyl cyclase (AC) inhibitor, 9-(tetrahydro-2-furanyl)-9H-purin-6-amine (SQ22536), were microinjected bilaterally (100 nl/site) into the PPT, and the effects on REM sleep in freely moving chronically instrumented rats were quantified [2].

High impact information on AX 100

  • Activation of monocytes by lipopolysaccharide resulted in the induction of MT1-MMP mRNA and protein that was suppressed by inhibitors of prostaglandin synthesis (indomethacin), adenylyl cyclase (SQ 22536), and protein kinase A (Rp-cAMPs) [3].
  • The lack of effect of dibutyryl cAMP, forskolin, and SQ 22536, an adenylyl cyclase inhibitor, on MMP-9 secretion by HSB.2 cells argued against any role for cAMP-dependent mechanisms linked to EP2/EP4 Rs [4].
  • Only in the tumor group, buserelin-induced ERK1/2 activation was cAMP dependent (abolished by SQ 22536, the adenylyl cyclase inhibitor) [5].
  • Each application of SQ-22536, an adenylate cyclase inhibitor, and H-89, a protein kinase A inhibitor, mimicked and occluded the effect of NPY [6].
  • The adenylate cyclase inhibitor SQ-22536 (10(-4) M), the cAMP blocker Rp-cAMP-S (10(-3) M), and the protein kinase A inhibitor H-89 (10(-5) M), although counteracting the ZG proliferogenic action of 10(-9) M ACTH, did not affect the 10(-8) M ADM-elicited increase in ZG DNA synthesis [7].

Biological context of AX 100


Anatomical context of AX 100


Associations of AX 100 with other chemical compounds

  • In "non responder" samples some factors--still to be defined--might counteract similarly to the compound SQ 22536 the antiaggregating activity of PGD2 [18].
  • Cells were treated with PGE2, protein kinase A (PKA) inhibitors H-89 or SQ 22536, protein kinase C (PKC) inhibitors calphostin C or GF 109203X, PKC activator phorbol 12-myristate 13-acetate (PMA), or the PKA activator forskolin [19].
  • Acceleration does not require the conventional transmembrane adenylyl cyclase ADCY3, since it persists in sperm of ADCY3 knockout mice and in wild-type sperm in the presence of the inhibitors of conventional adenylyl cyclases SQ-22536, MDL-12330A, or 2', 5'-dideoxyadenosine [20].
  • In vessels constricted with ACh, the diameter response to cumulative doses of ADM (10(-12)-10(-7) M) was measured in the presence and absence of human ADM-(22-52), calcitonin gene-related peptide-(8-37), N(omega)-nitro-L-arginine methyl ester (L-NAME), indomethacin (Indo), (1)H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one, SQ-22536, or KCl (60 mM) [21].
  • 5. 9-(Tetrahydro-2-furanyl)-9H-purine-6-amine (SQ-22536; adenylate cyclase inhibitor) and a myristoylated protein kinase A inhibitor did not inhibit the noradrenaline-induced effects and 8-bromo-cAMP had no effects on pacemaker currents [22].

Gene context of AX 100

  • Responses to CGRP were reduced by SQ-22536 and Rp-cAMPS, inhibitors of adenylyl cyclase and PKA [23].
  • To this end, diluted whole blood collected from 17 normal volunteers was incubated with fluoxetine (10(-6) and 10(-5) M), with or without SQ 22536 (10(-6) and 10(-4) M) and Rp-8-Br-cAMPs (10(-6) and 10(-4) M), afterwards, IFN-gamma, IL-10 and the tumor necrosis factor alpha (TNF-alpha) were determined [24].
  • These increases were significantly blocked by a specific PKA inhibitor H-89 (100 nM) and an adenylcyclase inhibitor SQ 22536 (200 microM) (72.5% and 60.1%, respectively) [25].
  • SQ 22536 (0.01-1.0 mM) and DDA (0.01-1.0 mM) completely blocked PTH stimulation of cAMP production measured in the absence of a phosphodiesterase blocker [26].
  • However, neither (1)H-[1,2,4]oxadiazolo-[4, 3-a]quinoxalin-1-one, SQ-22536, nor Indo alone altered dilation to ADM [21].

Analytical, diagnostic and therapeutic context of AX 100

  • Radioimmunoassay showed that, in the presence of a general phosphodiesterase inhibitor, PTHrP caused a concentration-dependent increase in intracellular cAMP content in arteries and veins, which was largely abolished by SQ-22536 [15].


  1. ATP stimulates Na+-glucose cotransporter activity via cAMP and p38 MAPK in renal proximal tubule cells. Lee, Y.J., Park, S.H., Han, H.J. Am. J. Physiol., Cell Physiol. (2005) [Pubmed]
  2. Novel role of brain stem pedunculopontine tegmental adenylyl cyclase in the regulation of spontaneous REM sleep in the freely moving rat. Datta, S., Prutzman, S.L. J. Neurophysiol. (2005) [Pubmed]
  3. Monocyte membrane type 1-matrix metalloproteinase. Prostaglandin-dependent regulation and role in metalloproteinase-2 activation. Shankavaram, U.T., Lai, W.C., Netzel-Arnett, S., Mangan, P.R., Ardans, J.A., Caterina, N., Stetler-Stevenson, W.G., Birkedal-Hansen, H., Wahl, L.M. J. Biol. Chem. (2001) [Pubmed]
  4. Regulation of expression of matrix metalloproteinase-9 in early human T cells of the HSB.2 cultured line by the EP3 subtype of prostaglandin E2 receptor. Zeng, L., An, S., Goetzl, E.J. J. Biol. Chem. (1996) [Pubmed]
  5. Gonadotropin-releasing hormone signaling pathways in an experimental ovarian tumor. Chamson-Reig, A., Sorianello, E.M., Catalano, P.N., Fernández, M.O., Pignataro, O.P., Libertun, C., Lux-Lantos, V.A. Endocrinology (2003) [Pubmed]
  6. Neuropeptide Y inhibits axonal transport of particles in neurites of cultured adult mouse dorsal root ganglion cells. Hiruma, H., Saito, A., Kusakabe, T., Takenaka, T., Kawakami, T. J. Physiol. (Lond.) (2002) [Pubmed]
  7. Adrenomedullin enhances cell proliferation and deoxyribonucleic acid synthesis in rat adrenal zona glomerulosa: receptor subtype involved and signaling mechanism. Andreis, P.G., Markowska, A., Champion, H.C., Mazzocchi, G., Malendowicz, L.K., Nussdorfer, G.G. Endocrinology (2000) [Pubmed]
  8. Endothelin-1 induces lipolysis in 3T3-L1 adipocytes. Juan, C.C., Chang, C.L., Lai, Y.H., Ho, L.T. Am. J. Physiol. Endocrinol. Metab. (2005) [Pubmed]
  9. Tonic inhibitory role for cAMP in alpha(1a)-adrenergic receptor coupling to extracellular signal-regulated kinases 1/2. Jiao, X., Gonzalez-Cabrera, P.J., Xiao, L., Bradley, M.E., Abel, P.W., Jeffries, W.B. J. Pharmacol. Exp. Ther. (2002) [Pubmed]
  10. Role of nucleotide cyclases in the inhibition of pregnant rat uterine contractions by the openers of potassium channels. Okawa, T., Longo, M., Vedernikov, Y.P., Chwalisz, K., Saade, G.R., Garfield, R.E. Am. J. Obstet. Gynecol. (2000) [Pubmed]
  11. Roles of nitric oxide and prostacyclin in triethyleneglycol dimethacrylate (TEGDMA)-induced vasorelaxation. Abebe, W., Maddux, W.F. Dental materials : official publication of the Academy of Dental Materials. (2006) [Pubmed]
  12. Allenic derivatives of nucleic acid components and their transformation products: a new class of biologically active nucleoside analogues. Phadtare, S., Zemlicka, J. Nucleic Acids Symp. Ser. (1987) [Pubmed]
  13. Effect of cyclic AMP level reduction on human neutrophil responses to formylated peptides. Spisani, S., Pareschi, M.C., Buzzi, M., Colamussi, M.L., Biondi, C., Traniello, S., Pagani Zecchini, G., Paglialunga Paradisi, M., Torrini, I., Ferretti, M.E. Cell. Signal. (1996) [Pubmed]
  14. Vasorelaxant effects induced by the antiangiogenic drug linomide in aortic and saphenous vein preparations of the rabbit. Amerini, S., Filippi, S., Parenti, A., Ledda, F., Ziche, M. Br. J. Pharmacol. (1997) [Pubmed]
  15. Parathyroid hormone-related protein-mediated responses in pulmonary arteries and veins of newborn lambs. Gao, Y., Raj, J.U. Am. J. Physiol. Lung Cell Mol. Physiol. (2005) [Pubmed]
  16. Mechanisms underlying hyperpolarization evoked by P2Y receptor activation in mouse distal colon. Zizzo, M.G., Mulè, F., Serio, R. Eur. J. Pharmacol. (2006) [Pubmed]
  17. Is cAMP the obligatory second messenger in the action of lutropin on Leydig cell steroidogenesis. Themmen, A.P., Hoogerbrugge, J.W., Rommerts, F.F., van der Molen, H.J. Biochem. Biophys. Res. Commun. (1985) [Pubmed]
  18. SQ 22536, an adenylate-cyclase inhibitor, prevents the antiplatelet effect of dazoxiben, a thromboxane-synthetase inhibitor. Bertelé, V., Falanga, A., Tomasiak, M., Cerletti, C., de Gaetano, G. Thromb. Haemost. (1984) [Pubmed]
  19. Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Müller cells. Cheng, T., Cao, W., Wen, R., Steinberg, R.H., LaVail, M.M. Invest. Ophthalmol. Vis. Sci. (1998) [Pubmed]
  20. Signaling pathways for modulation of mouse sperm motility by adenosine and catecholamine agonists. Schuh, S.M., Carlson, A.E., McKnight, G.S., Conti, M., Hille, B., Babcock, D.F. Biol. Reprod. (2006) [Pubmed]
  21. Human coronary arteriolar dilation to adrenomedullin: role of nitric oxide and K(+) channels. Terata, K., Miura, H., Liu, Y., Loberiza, F., Gutterman, D.D. Am. J. Physiol. Heart Circ. Physiol. (2000) [Pubmed]
  22. Noradrenaline inhibits pacemaker currents through stimulation of beta 1-adrenoceptors in cultured interstitial cells of Cajal from murine small intestine. Jun, J.Y., Choi, S., Yeum, C.H., Chang, I.Y., Park, C.K., Kim, M.Y., Kong, I.D., So, I., Kim, K.W., You, H.J. Br. J. Pharmacol. (2004) [Pubmed]
  23. Responses to human CGRP, ADM, and PAMP in human thymic arteries. Champion, H.C., Bivalacqua, T.J., Pierce, R.L., Murphy, W.A., Coy, D.H., Hyman, A.L., Kadowitz, P.J. Am. J. Physiol. Regul. Integr. Comp. Physiol. (2003) [Pubmed]
  24. The negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway. Maes, M., Kenis, G., Kubera, M., De Baets, M., Steinbusch, H., Bosmans, E. Int. Immunopharmacol. (2005) [Pubmed]
  25. Cyclic AMP-dependent protein kinase A and CREB are involved in neuregulin-induced synapse-specific expression of acetylcholine receptor gene. Kang, B.H., Jo, I., Eun, S.Y., Jo, S.A. Biochem. Biophys. Res. Commun. (2003) [Pubmed]
  26. Adenylate cyclase blockers dissociate PTH-stimulated bone resorption from cAMP production. Reid, I.R., Lowe, C., Cornish, J., Gray, D.H., Skinner, S.J. Am. J. Physiol. (1990) [Pubmed]
WikiGenes - Universities